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concept of certain new etiologic forces which lie back of those which were
once thought to be basic such as, for instance, the factors which lie back of
the pneumococcus as a cause of pneumonia. Of late years conservative
opinion does not allow anything to be really considered as 'etiology' unless
we can succeed in getting it into a test tube, unless we can precipitate it,
-unless we can crystallize it as it were. This is due, of course, to our
current methodology which has, perhaps, become more of a religion than
most of us realize. I think it may have led to a slightly narrow interpre-
tation of clinical investigation on our part, for clinical investigation certainly
should be given the opportunity to spread itself up into philosophy, if it
will, as well as down into the basic sciences."
In the twenty-three years since these words were written, progress has
been made; with considerable struggle, epidemiology is coming into its
own as a basic and a clinical science, and its potentialities, forseen so clearly
by Dr. Paul, are gradually being realized. During these years, he has been
in the thick of the battle as an investigator and teacher, organizing and
carrying out both frontal and flank attacks on various epidemiological prob-
lems at home and abroad. A year and a half ago, he had occasion to dictate
an informal history of research in the Section of Preventive Medicine, with
some notes on earlier work carried out while he was assistant and associate
professor of Medicine. The transcription of this dictation he has never seen.
Nevertheless, we are taking the liberty of presenting it here, without his
knowledge (and with only minor editing) as a personal record of the
pleasures of scientific exploration and discovery in the mid-20th century




FROM THE NOTEBOOK OF JOHN RODMAN PAUL
"At an earlier date, some four or five months ago, I dictated an outline of
the activities of the Department of Medicine during the 1920's and '30's
with emphasis upon the work of Blake and Trask on scarlet fever, their
recognition of the scarlatinal toxin, and the use of antisera in the therapy
of the disease. This was at a time when scarlet fever was a much more
serious disease than it is at present. The report also emphasized Dr. Blake's
work on pneumococcal pneumonia, his discovery and classification of
pneumococcus variance, and later a great deal of work on the therapy of
pneumonia, both by pneumothorax and later by chemotherapy and anti-
biotics.
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From the work on scarlet fever, a disease of streptococcal origin, a num-
ber of lines of research developed. One of them included the studies on the
epidemiology of rheumatic fever, which began before the role of the
hemolytic streptococcus was appreciated. These studies utilized the family
approach. On the basis of the way rheumatic fever spread through families,
it was concluded that respiratory infection of some kind precipitated the
acute attack of the disease. Rheumatic fever studies covered a period of
at least eight years. During this time many of the environmental and
social aspects were explored through intimate, long term studies on all
members of 122 rheumatic families, and suitable control families. Some
sixteen years later in 1947 many of the families were re-studied by Dr.
Freida Gray and Dr. Robert Quinn.
DISCOVERY OF THE HETEROPHILE ANTIBODY TEST FOR THE
DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS
The events which led to the discovery of this diagnostic test may be
of some interest. In 1929, Davidson of Chicago published a paper indicating
that agglutinins to sheep cells were present in cases of serum sickness and
he elaborated on the fact that this was an example of the Forssman antigen
which had been demonstrated in 1911. It had been found that cells obtained
from the organs of many animals when injected into an appropriate animal,
such as a rabbit, were capable of giving rise not only to specific anti-
bodies but also to nonspecific antibodies and these were demonstrable in
varying degree in the form of hemolysins and agglutinins for sheep cells.
Serum sickness was a very common disease in the New Haven Hospital
during the period between 1928 and 1930, the widespread use of serum for
cases of scarlet fever and for pneumonia providing plenty of clinical
material. Davidson's results were quickly confirmed at the Yale Laboratory.
At the same time, a study on rheumatic fever was going on, and the
question arose as to whether the similarity of symptoms between rheumatic
fever and serum sickness might not make it worthwhile to look for this
heterophile antibody in cases of rheumatic fever. Such a search was started
but we were unable to demonstrate a consistent or appreciable increase in
the heterophile antibody content of the serum of patients suffering from
rheumatic fever.
In the course of this study however, a number of controls from individuals
suffering from serum sickness and a variety of other clinical conditions
were assembled. Quite by accident it was discovered that antibodies capable
of agglutinating sheep cells were present in the specimen of serum of a
patient ill with infectious mononucleosis. The titer of antibody in this
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serum was much higher than had been described in serum disease or
in any other clinical condition which we had studied. The man who was
collecting the specimens of serum from the "control" patients was Dr. W.
W. Bunnell, now a well-known practitioner of medicine in Farmington,
Connecticut, and the patient on whom this discovery was made was a
medical student, Mr. Franklin Foote, now a physician, and Commissioner
of Health of the State of Connecticut. The finding seemed to be unusual
and something of a fluke. It was not until a good seven or eight months
later that another case of infectious mononucleosis came to our attention;
this time also it was a medical student with infectious mononucleosis and
jaundice and here again a high heterophile antibody titer was demonstrable.
Gradually a series of infectious mononucleosis cases was assembled and it
seemed that this was a fairly characteristic finding. The first paper, "The
Presence of Heterophile Antibodies in Infectious Mononucleosis," was
published in 1932, and covered a series of some 275 general hospital
patients in which the test had been carried out, mostly with negative
results, with the striking exception of the positive findings in the cases
of infectious mononucleosis. That the test would be useful in diagnosis was
established essentially by Dr. Bunnell, who in the subsequent year
gathered a much larger series of cases. In view of the simplicity of the
test it was not long before reports began to appear from many laboratories
and almost immediately it was pointed out that the type of antibodies
present in infectious mononucleosis differed from those present in serum
disease, and the two could be differentiated by absorbing the serum with ox
cells or guinea pig kidney. Some of these papers criticized the Yale workers
for calling this a heterophile antibody, and a lively discussion appeared in
the medical literature. One of the valuable letters in the archives of this
study was that received from Nobel Laureate Carl Landsteiner, who wrote
that he was in real sympathy with our calling this a heterophile antibody
regardless of the critics. As a postscript to the finding it may be said that
although the test is widely used today, the etiology of this disease remains
an enigma.
THE YALE POLIOMYELITIS STUDY UNIT
The story of the work on poliomyelitis begins in 1931. This was under-
taken jointly by the Departments of Medicine and Pediatrics, and as a
result the Yale Poliomyelitis Study Unit was founded. It was a logical out-
growth of the setting from which it arose. The Department of Internal
Medicine and, to a lesser extent, the Department of Pediatrics at the Yale
University School of Medicine in 1930 were both more or less dedicated
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to the study of the natural history of infectious disease, as well as to
metabolic aspects of disease. There were two major divisions, - infectious
and metabolic - in each of the two departments. Francis Blake who headed
the infectious disease division of the Department of Medicine had trained
Dr. Trask, and had shown him how effective research in the field of infection
could be. Dr. Blake and Dr. Trask had carried out studies on experimental
measles in monkeys at the Rockefeller Institute in 1920-22. As a result,
Dr. Trask was experienced in the handling of these expensive, and at that
time, unusual experimental animals which subsequently proved so essential
for research on poliomyelitis.
In 1931 there were only about three or four virus laboratories in the
United States which could be said to be primarily concerned with investi-
gations on the etiologic agent of poliomyelitis. These were the laboratory
headed by Dr. Simon Flexner at the Rockefeller Institute for Medical
Research in New York City, the Harvard Infantile Paralysis Commission
in Boston under the direction of Dr. Lloyd Aycock, the laboratory in the
New York City Department of Health under Dr. W. H. Park, and finally,
the Department of Bacteriology at the College of Physicians and Surgeons
of New York where Dr. C. W. Jungeblut was working primarily on the
endocrine influences which might condition the host and render him more
susceptible to poliomyelitis virus. At this same institution Jungeblut's
approach had been championed by Dr. George Draper who had become a
unique figure in the clinical field of acute poliomyelitis, having been the
physician in charge of Mr. Franklin D. Roosevelt's case. In the late 1920's
Dr. Draper had been placing much emphasis on host factors and he was
inclined to believe that work on poliovirus, in which he had been originally
interested, was now outmoded. In any event, in 1931 clinical virology was
not listed as a major research fashion; so that it was essentially the intro-
duction of the spirit of clinical investigation and what might be termed
clinical epidemiology into the field of poliomyelitis which the Yale group
(under Dr. Trask and Dr. Paul) accomplished. Indeed, their opportunity
was thrust upon them with the onset of an extensive poliomyelitis epidemic
which began in New Haven in June, 1931.
The immediate aim of the workers at Yale was to devise a means of
isolating the virus from patients, not only from spinal cords of fatal
cases as had been the current practice, but in a bolder plan, from mild
abortive or nonparalytic cases as well as severe paralytic ones. In planning
these virus studies we had been impressed by a recent experience in the
previous year in the nearby town of Middletown, Conn. This community
had suffered an autumn epidemic in 1930 of some twenty or more cases.
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It had been our privilege to see some of these patients and to note that
there had been all grades of severity among them. Many a suspected case
had not only no paralysis but little or no stiff neck. Virus studies would have
helped materially in making the diagnosis. Thus when a similar epidemic
situation appeared in New Haven the following spring, the development
of diagnostic techniques for the isolation of virus from clinical cases both
severe and mild, particularly from individuals who had the so-called minor
illness, seemed to be the first thing to try to do.
These plans met with very little support from anyone except Dr. W. H.
Park of New York City. Consultations were held with him and also with
Dr. Flexner and Dr. Aycock; the latter two strongly advised against this
approach as one which was expensive and would not yield valuable results.
No positive isolations from the throat had been obtained by anyone in
thirteen years and the idea of obtaining poliovirus from the feces had been,
according to Dr. Flexner, completely disproved. Monkeys cost from six
to eight dollars each. This was regarded as an expensive laboratory
animal, and it was deemed unwise for amateurs to spend so much money
on this type of research, particularly when it was their initial piece of
work in this field and there were many more orthodox things to be done.
Nevertheless, it seemed to Dr. Trask and his colleagues that the clinical
situation and the recent memory of the 1930 Middletown experience cried
out for virus studies on all members of families in which poliomyelitis was
suspected. We saw family after family through which there had swept a
simultaneous wave of minor illnesses, limited to headache, vomiting, fever
and sore throat and occasionally in one member, signs of central nervous
system involvement. The usual diagnosis given to these family epidemics
was summer grippe. In any event, two strains of poliovirus were isolated
from the throats of two cases of "abortive poliomyelitis" that summer and,
although for the next three or four years these results were severely
challenged by experts, they stood the test of time. During this time the
Yale Poliomyeliis Study Unit was supported with considerable diffidence by
the Fluid Research Fund of Yale University and a series of small grants
from various sources, including the Philadelphia Poliomyelitis Fund, an
anonymous donor, the National Research Council, and the Rockefeller
Foundation. Starting in 1936 we received the first research grant ever
given by the President's Birthday Ball Commission which eventually be-
came the National Foundation for Infantile Paralysis, and finally the
National Foundation. The earliest grants amounted to two or three thousand
dollars, and by the late 1930's they ran to about twelve thousand dollars, a
modest sum indeed compared with grants of today.
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But to return to the interests of the Yale Laboratory in the 1930's:
it was at this time that the Study Unit set for itself the task of determining
whether there was more than one strain of poliomyelitis virus in the United
States. A pioneer paper on this subject had already been published in
1931 by Burnet (later Sir Macfarlane) and McNamara from Australia. This
paper had been received in the United States with some incredulity and
the feeling that there was no telling what kind of poliovirus there might
be in such far off places as Australia, but "it can't happen here." One
of the most significant papers ever published by members of the Yale
Poliomyelitis Study Unit was that designated as number 9 on its list. It
appeared in 1933 and clearly described the immunological difference be-
tween two strains, as demonstrated by cross-immunization reactions and
testing the resistance of monkeys by challenge with homologous and
heterologous viruses. This work was carried forward for at least three
years and by 1937 it was felt that one could divide the poliomyelitis virus
family into at least two and possibly three types. In retrospect, whether
we actually had a Type III poliovirus in our collection of strains is not
absolutely clear. In any event, the work led in the not too distant future
to the recognition that the poliovirus family consists of three members.
In the course of these experiments a number of monkeys which had
been supposed to be immunized by inoculating them intracutaneously with
formalinized virus, actually developed paralysis. The experimental use of
formalinized vaccines as a method of immunizing monkeys brings up the
inevitable question as to whether their use in man was contemplated at
this early date by the Yale Poliomyelitis Study Unit. The answer is
that in the mid-1930's this was a dominant theme in poliomyelitis research
and immunization with formalin killed virus was being tried by Dr. Kolmer
in Philadelphia and by Dr. Brodie of New York. Their work was unsuc-
cessful, however, and the occurrence of possible vaccine induced cases gave
a black eye to the idea of a killed poliovirus vaccine. Had the Unit worked
on the subject then, it is probable that much time and effort might have been
wasted because the separation of the family of polioviruses into different
strains was very crude indeed. Furthermore, at the time infected monkey
spinal cord was the only source of virus antigen; the development of a
practical vaccine had to await the dawn of the tissue culture era fifteen
years later.
The next item of considerable interest was the project undertaken in
1935 by members of the Unit who collected from the literature all examples
of studies on serum antibodies in normal inhabitants in different parts
of the world. This was the first study on serological epidemiology of any
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import, and the results, to our surprise, indicated that the highest rates of
poliovirus antibodies occurred in tropical areas where the disease was
supposed not to occur. At that time this seemed a paradoxical and un-
orthodox finding.
In 1937 the Unit was successful in isolating poliovirus from the feces
of a child in the New Haven Hospital. Isolation of poliovirus from feces
had been achieved once before by a Swedish group headed by Dr. Kling
of Stockholm, but their experiments had been challenged by Dr. Flexner.
Since 1932 the Yale Poliomyelitis Study Unit had attempted to repeat the
work of Dr. Kling and his colleagues but the route of inoculation at that
time, that is, into the brain of the monkey, was hazardous because of
frequent bacterial contamination and brain abscesses, and no positive
results were achieved. Besides, monkeys were limited in quantity and so
expensive that it seemed wasteful to pursue this approach. The discovery
which led subsequently to widespread use of fecal material in the study of
the epidemiology of poliomyelitis came by pure chance. We happened to
have a pet monkey in the laboratory named Bosco who was quite a beautiful
animal of African origin, a Cercopithecus monkey which we had been
conserving for no good scientific purpose at the cost of $1.00 per month.
And yet no one had had the heart to use him on an experiment which might
cause paralysis or early demise. In October, 1937 a poliomyelitis patient
named Skolnick was admitted to the Pediatric Service of the New Haven
Hospital and Dr. Alfred Vignec of that service, and Dr. Paul went to the
home of this patient where an infant sibling was found to have fever but
seemed otherwise normal. Throat washings and a stool specimen, whicb
was conveniently produced at the time of the visit, were collected. It was
at the suggestion of Dr. Vignec (now a well-known pediatrician of New
York City) that the extract of fecal material from the Skolnick infant was
inoculated intraperitoneally into Bosco. Both Dr. Trask and Dr. Paul, and
last but not least, the faithful animal caretaker* who was devoted to Bosco,
firmly believed that he would safely survive this procedure. But Bosco was
paralyzed in all four limbs within a few days of inoculation and, sad as his
death was, it opened up a large new field, quickly exploited by the Polio-
myelitis Study Unit, even though the idea of isolating a virus from feces
had very little appeal at that time to most good contemporary micro-
biologists. As for poliomyelitis, the accepted theory was that this was a
disease in which the agent was spread by way of the respiratory tract.
It soon became obvious that it was far easier to find poliovirus in the
* Mr. Alfred Coppola, now working in the Department of Physiology in the same
capacity.
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feces of patients ill or recently ill with poliomyelitis, than to find the
virus in their nasopharyngeal washings, the customary source of virus
isolation from living patients. Nevertheless, the devotees of the respiratory
transmission theory of the virus still held out.
Following the detection of poliovirus in human feces and the use of
stool isolations as an epidemiologic tool, it was a short step to see whether
the virus could be demonstrated in sewage. This was soon found to be
very easy. The first report on isolation of poliovirus from sewage came
from the Yale Laboratory in 1939. Shortly after this a successful effort
was made to determine the presence or survival of the virus in flies, par-
ticularly the filth flies whose favorite food is feces. These investigations,
which came fast upon the heels of one another, gave the Yale Laboratory
the reputation that it believed that poliomyelitis was a water-borne disease
spread by sewage! It is true that the laboratory had stated early in 1939
that it was logical to regard poliomyelitis as an "intestinal disease" and
this pronouncement had been greeted with some dismay on the part of our
friends who felt that we had done good work up until then but had finally
''gone off the deep end." Actually the attitude which the laboratory soon
took was that the presence of poliovirus in sewage provided a useful
epidemiological tool, but there was no implication that the agent was
spread by sewage. It was pointed out that sewage is full of pathogenic
organisms including tubercle bacilli, but this does not mean that sewage
is the usual vehicle of transfer of tubercle bacilli.
One of the uses to which the sewage findings were put was to test a
theory largely promoted during the 1930's by Dr. Lloyd Aycock of the
Harvard Infantile Paralysis Commission. The idea was that there was just
as much poliomyelitis infection present in a community during the winter
as in the summer, but there was a seasonal lack of resistance on the part
of the human host which made him succumb to paralytic poliomyelitis in the
summer. This lack of resistance was given the name "autarcesis" and it
was produced somehow or other supposedly by hot weather. The discussions
about this went on pro and con between Harvard and Yale for several
years. It is possible that there was something in Dr. Aycock's argument, but
in any event to prove or disprove his theory we went to great lengths. We
sampled the sewage of a particular district in New York City each month
over a period of six years in order to find out whether poliomyelitis virus
was present there regularly month in, month out, during non-epidemic
times, as well as during epidemics, as Aycock had predicted. Our findings
indicated that poliomyelitis virus, detected by the cumbersome method of
monkey inoculation then in use, was present in the raw sewage of New
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York City only during the summer and fall and most frequently when
there were actual cases of poliomyelitis being reported there.
The presence of poliomyelitis virus in flies is another story. The actual
role which they play in the dissemination of the disease has never been
established but it seems very probable that in areas that are teeming with
flies such as Cairo, Egypt, they do play a role. This evidence is supported by
the experiments carried out in the Yale Laboratory in 1943 by Ward,
Melnick, and Horstmann, who found that flies in an epidemic area can
contaminate food with poliovirus, and when such contaminated food was
fed to chimpanzees, poliovirus infection was induced in them. This indicated
that flies could at least be mechanical carriers of the virus of poliomyelitis.
Arguments as to how important flies are in the usual spread of the disease
have been pursued for twenty years without reaching final conclusions. Two
projects have been carried out in this laboratory over the years, the first
one by Dr. Melnick and others, and a more recent one by Dr. Margret
Gudnadottir, a fellow from Iceland. The work indicated that flies can main-
tain the virus for a period of two weeks, and Dr. Gudnadottir's findings
suggest that slight multiplication does take place in the body of the fly.
However, there is no evidence that flies play an essential role in the trans-
mission of the virus in the manner in which mosquitoes are essential in the
transmission of yellow fever or malaria.
The story of the work of the Yale Poliomyelitis Study Unit would be
incomplete without emphasis upon the field work carried out during the
1930's. It is difficult today for us to realize how helpless physicians and
health officers were in this period in the face of a severe poliomyelitis
epidemic. Having issued proclamations in the newspaper, and quarantined
the exposed households, there was little else they could do. However, it
became fashionable for the health officers to call in a team of epidemiologists
or research workers. They did not expect much from these workers but the
feeling was that the presence of consultants or of a team of experts might
give the public the impression that at least something was being done. This
launched the Yale laboratory on a series of clinical epidemiological studies
which gave us an opportunity to see the disease first hand in various
locations. At first it was our practice to spend a month to six weeks in
each epidemic area; in several of these a laboratory was set up complete
with facilities for housing monkeys and inoculating them on the spot. Later
with the advent of airplane travel, a series of short visits were generally
made. Epidemiological studies of various types were carried out starting
in New Haven in 1931; Philadelphia in 1932; in Los Angeles in 1934; in
Toronto, Canada in 1937; in Charleston, South Carolina in 1939, also
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in that same year in Detroit, Michigan, and Buffalo, New York; in 1940,
in Indianapolis, Indiana and in Huntington, West Virginia; in 1941 Miami,
Florida, Cordova, Alabama, and Winnipeg, Canada, to mention only a few
of these expeditions. It is hard to imagine the excitement and the misguided
publicity which attended the arrival of the research workers in an epidemic
area in the 1930's. In the long run, however, the time and effort spent in
these endeavors cannot be considered wasted. Occasionally there was bitter-
ness on the part of local research workers, but more often these ventures
spelled the beginning of fine pieces of collaboration.
In the 1940's there came a new stage of investigation and the first half
of this decade was taken up with problems in connection with World
War II. Early in 1941 with the formation of the Army Epidemiology Board,
a Commission on Neurotropic Virus Diseases was formed as a part of this
Board, and the directorship was established in the Yale Laboratory (Dr.
Paul). The mission with which the Commission was charged was to study
the arthropod-borne virus diseases and poliomyelitis in members of the U.S.
Armed Forces. Early in the war it was felt that poliomyelitis was certainly
not a military disease, but this was soon to be disproved and several out-
breaks in Army camps, suchas Fort Brooke in SanAntonio, Fort McClellan
in Alabama, required the assistance of members of this commission. Prom-
inent among its members were Dr. Trask, Dr. Robert Ward and, as
assistant, Dr. Melnick. In May of 1942 Dr. Trask, the leader of the Yale
Poliomyelitis Study Unit, died at the age of 52 while working in an Army
camp in Illinois. It was a very severe blow to his colleagues and to the
Commission and to the cause of poliomyelitis. Through the influence of
the National Foundation for Infantile Paralysis, Mr. Basil O'Connor, its
President, made special provision that a 10,000 ton Liberty Ship built
and christened in the shipyards of Baltimore, Maryland in May 1944, be
given the name, The James D. Trask, in memory of this singularly able
scientist and clinician, in recognition of his contribution to the study of
poliomyelitis.
In 1943 the forces of the Commission were divided with Dr. Paul
heading a small group (including Major Albert Sabin and Lt. Col.
Cornelius Phillip) known as the Virus Commission of the Army Epidemi-
ological Board, which was dispatched to North Africa to study problems in
connection with infectious hepatitis, sandfly fever, and poliomyelitis. The
team that remained at home consisted of Drs. Ward, Melnick, and Horst-
mann who were very active in clinical investigative work carried out during
the epidemic of poliomyelitis which visited New Haven during that summer
of 1943 and about which a number of important papers were published.
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The story of poliomyelitis in North Africa is worth repeating. During
the winter of 194243 there had been received at the Rockefeller Institute
several specimens of central nervous system tissue originally obtained from
fatal cases of myelitis and encephalitis occurring in British soldiers serv-
ing in the Middle East Forces. This was the period of World War II when
the Middle East was the most critical area. Rommel had come within a
short distance of Cairo. The German plan was to take Stalingrad and even-
tually as part of a pincers movement to work south to join forces with the
Afrika Korps. It was at the Battle of El Alamein in early October of 1942
that Montgomery and the British Eighth Army had upset Rommel's plans,
and these plans were to be further upset early in November with the landing
of U.S. troops in North Africa, in French Morocco and Algeria. During
this period British troops in the Middle East and the Mediterranean area
had been severely plagued with epidemics of viral hepatitis. They also had
begun to have sporadic cases of a serious disease of the central nervous
system, often with ascending paralysis, and in many instances, with a fatal
outcome. Was this poliomyelitis? Certainly encephalitis or poliomyelitis had
not been the experience of previous British armies in Egypt. Furthermore,
poliomyelitis was said to be rare among the civilian population of Egypt and
other areas of the Middle East. In Egypt not more than five or six civilian
cases per year had been reported in the late 1930's among the native
population of 16,000,000 people!
It was but a matter of a few weeks to determine that the central nervous
system tissue sent to this country and examined first at the Rockefeller In-
stitute contained poliomyelitis virus. This finding was one of the reasons that
our Commission was sent over to North Africa to investigate the situation.
On arrival in Cairo, the laboratory was set up in conjunction with the 38th
U.S. General Hospital (the Jefferson Medical School Hospital), and work
was commenced at once on the cases of suspected poliomyelitis in U.S.
troops which began to come in some numbers. Medical officers of the
U.S. Army, especially the neurological consultants, were very skeptical
about the clinical diagnosis of these cases. The clinical picture did not con-
form to their ideas of adult poliomyelitis, but the repeated isolation of strains
of poliovirus from such cases was eventually convincing. The virus isolation
work was carried out in monkeys which had to be obtained locally. Some
of the members of the Commission (J.R.P.) had to visit Ethiopia in order
to trap their own animals and bring them back to the laboratory in
Cairo.
It was in this setting that an important epidemiological idea began to
come into being. It grew out of the observation that adult poliomyelitis
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could exist and even thrive among visitors (i.e. susceptible immigrants) in
an areawhere onlyinfantile paralysis had been previously recognized; where
even that was thought to be very uncommon; and where adult poliomyelitis
among the native inhabitants was unknown. This indicated that young men
of military age coming from countries with high standards of hygiene in
which epidemic twentieth century poliomyelitis was plentiful enough, -
such young men were highly susceptible when introduced into regions where
sanitary arrangements were about as primative as could be imagined. Thus
on exposure to populations in which poliovirus infection was probably
endemic, they became infected readily, and as a result poliomyelitis began
to crop up in the soldiers from England and from the United States. It
seemed that poliomyelitis had become a military disease during the gener-
ation which separated World War I from World War II. During this
period, in many of the more "developed" parts of the world it had been
noticed that the age at which the disease was occurring had been pushed
up a decade or more. In other words, people were acquiring poliovirus
infections later in life than they had before, and as a result many arrived at
military age without having had the benefit of previous inapparent im-
munizing infections. This was but one of the many examples of the
changing pattern of poliomyelitis which subsequently became evident.
During this early part of the 1940's the Yale laboratory continued to send
out teams to carry on field work in epidemic areas. Notable among these
expeditions were those to Hickory, North Carolina in 1944, to Western
New York State in the same year; to Patterson, New Jersey, and to Rock-
ford, Illinois in 1945.
By the end of the 1940's some very important discoveries had been made.
Previously Dr. Charles Armstrong of the National Institutes of Health
had indicated that one strain of type II poliovirus would infect mice, an
enormous boon to laboratory workers. Later, working under the National
Foundation for Infantile Paralysis, a team of investigators in several labora-
tories had separated the polomyelitis virus family quite definitely into a
group of three, types I, II, and III. This brought considerable order out
of great chaos. And finally, in 1948 came the monumental discovery by Drs.
Enders, Weller, and Robbins that the virus of poliomyelitis could be grown
in tissue culture. The importance of this was not fully appreciated at first,
but it was one of the greatest milestones in the history of the disease.
During the latter half of the 1940's the Yale Poliomyelitis Study Unit
busied itself in large measure with developing the concept that poliomyelitis
was a disease in which the epidemiologic picture differed in different parts
of the world. Further studies on the distribution in troops in World
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War II, particularly in Japan, brought forth some interesting findings
indicating that the rate at which soldiers acquired the disease in the
Philippines, China, Burma, and India was ten times greater than the rate
at which the disease was acquired by troops of similar age who remained at
home.
Very shortly after these observations were made, a dramatic example of
the behavior of poliomyelitis in highly susceptible populations in the arctic
occurred in the form of an epidemic among Canadian Eskimos in
1948-49. There, in the fall of 1948, the disease was first introduced into
settlements along the west coast of Hudson Bay. It spread rapidly north-
ward where the epidemic eventually involved almost twenty per cent of
the entire population with paralytic disease. All age groups were attacked,
the highest rates of paralysis occurring in adults, and the lowest in infants!
Stimulated by this event, the Yale Poliomyelitis Study Unit (J.R.P.)
made an expedition in 1949 to Point Barrow on the north coast of Alaska,
where in connection with the Arctic Research Laboratory an attempt was
made to see whether the non-immune character of the Eskimos living in
that part of the world could be demonstrated by serological means. Available
tests for carrying out a study in serological epidemiology at the time
were crude but, nevertheless, the study did prove of considerable value.
It was found that among the members of the Point Barrow community
virtually none under the age of twenty possessed antibodies to type II
poliovirus, whereas about seventy per cent above twenty years did possess
such antibodies. The ages of persons with type I antibodies was 35 and
over, and with type III, 45 and over. This was a pilot study in serological
epidemiology and opened a whole new field. It appeared that from the
determination of the pattern of antibody distribution on an age specific basis,
it was possible to retrace the history of an infection in an area where little
or no accurate vital statistics had ever existed.
As a quick corollary to the Alaskan study, the next expedition which the
Study Unit organized (and J.R.P. carried out) was to a part of the world
which was selected because it is as completely opposite to barren arctic
wastes as could be imagined, namely to a crowded Egyptian village in
the outskirts of Cairo. It was felt that if the population of Cairo was
sufficiently immune so that no adults ever acquired clinical poliomyelitis,
it should be possible to document this fact in their antibody patterns.
Such was indeed found to be the case: by the time they reached 3 or 4
years of age virtually all Egyptian children had antibodies to the three
types of poliovirus. As an important by-product of this study, an alert
graduate student working in the Section of Preventive Medicine found that
174
Vol. 34, Dec.-Feb. 196112From the notebook of J. R. Paul
in some of the bloods which were being tested for antibody content there
was a virus present, and this agent was quickly identified with the help
of Dr. Melnick as West Nile Fever virus. This virus has subsequently been
shown to be the cause of a great deal of mild febrile illness in Egypt and
in Israel. Although it had been discovered ten years earlier in Central
Africa, the agent had never before been found so far north in Africa, and its
importance as a producer of illness had gone unappreciated for many years.
Credit for this discovery is due to Miss VoHammie Barnett who died
a few months after making this remarkable observation.
Subsequently, serological surveys were carried out by the Yale group
in other populations. These included the populations on the island of
Tahiti, in Morocco, North Africa, in North Carolina, and later in Guatemala,
Central America. During this period there was a sudden increase in the
use of the antibody survey as a method of determining the immune status
of given populations throughout the world.
Also in the 1940's, came the discovery of the Coxsackie group of viruses
by Dr. Gilbert Dalldorf and Miss Grace Sickles. Dr. Melnick immediately
became interested in work with these agents. Together with Dr. Edward
C. Curnen, strains were isolated from cases of aseptic meningitis. Sub-
sequently, Dr. Melnick and his collaborators were in the forefront in
classifying this large family of agents, characterizing their physical prop-
erties, and studying their pathology, serology, and epidemiology.
We come now to a new decade and a new era in the history of polio-
myelitis, for the 1950's marked the beginning of the era of the development
of active immunization. The advent of the tissue culture method and the
discovery that poliovirus produces a cytopathogenic effect on tissue culture
cells by which its presence can be detected, enormously facilitated research
work in this field. It was possible not only to isolate poliovirus readily and
demonstrate antibodies, but means were now available for preparing a
vaccine. On this basis, the work of Dr. Salk began early in 1952 and pro-
gressed successfully to the production of the vaccine for general use in
April 1955. We have been asked many times why the Yale Laboratory
having had such a fine background and having begun work on this very
subject in 1936, never really pursued it to a satisfactory conclusion. Actually,
the first formalinized killed vaccine antigens were administered by the Yale
Poliomyelitis Study Unit in 1931 when Dr. Trask and Dr. Paul both
were inoculated with small doses of formalinized vaccine to see if they
could boost their own antibodies and quantitatively demonstrate this in the
clumsy neutralization test in monkeys. It was not, obviously, a successful
procedure. Killed vaccines had a bad name in the mid and late 1930's
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and the antibody tests were so poor that a book was written discrediting
them almost completely.
The next efforts of the Unit to immunize man were made in 1946. A
rather unfortunate choice was made at this time in that heat killed mouse
brain virus was selected as the antigen for a vaccine. The decision to use
heat inactivation rather than formalin was based partly on our earlier
immunization experiments in monkeys carried out from 1935 to 1938; in
several instances the formalin had failed to kill the poliomyelitis virus and
we felt insecure about its adequacy. Obviously, we did not know how
to use it. Our first vaccination trial in man was an effort to boost anti-
bodies by inoculating the heat killed antigen. This work was carried out in
Miami, Florida in 1946 by Dr. Horstmann. The method of measuring anti-
body rises by intracerebral neutralization tests in mice left a good deal
to be desired. The results were not particularly successful; had they
been a little more promising, we would have pushed forward at that time
with all possible speed.
During the period 1946-49 we continued experiments on the use of
heat killed antigens which were used not only in attempting to develop
a skin test, but in an effort to immunize man. The work was carried out
at the Southbury Training School, Southbury, Connecticut. At first we
used as antigen the YSK (type II poliovirus) propagated in cotton rats,
and heat inactivated at 700 for thirty minutes. Eventually, it was found
that by concentrating the antigen one hundred times by ulracentrifugation,
and by reducing the heat of inactivation from 70° to 60° C. the antigenicity
was improved. In fact three of fourteen individuals tested showed rises in
antibody after inoculation of this preparation. Unfortunately heat
causes deterioration of the antigen to a far greater degree than does
formalin; if only the result had been a little better than 20%o we would have
gone forward on this lead. At the same time we began to work with oral
immunization with heat killed material and shortly thereafter Dr. Melnick
began to work on the attenuation of poliovirus strains which might be used
in a vaccine. In all these experiments the results were a little under the
level which would have caused us to pursue them with greater vigor.
In 1951, Dr. Horstmann again began work on the question of viremia in
poliomyelitis. This had been studied in 1943, but at that time virus had
been isolated from the blood of only 1 of 111 patients with the disease, and
the conclusion was reached that viremia was rare and unimportant in the
pathogenesis of poliomyelitis. In 1951 and 1952, however, we found
that orally infected monkeys and chimpanzees regularly had virus in the
blood. However, viremia was detected only in the incubation period and
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not after signs of the disease appeared. In the summer of 1952 Dr. Horst-
mann and Dr. Robert McCollum demonstrated viremia in human infections,
in blood specimens collected from family contacts of paralytic cases,
from those with asymptomatic infections, and from children with the "minor
illness", the study having been carried out during an epidemic in Ohio.
At about the same time in 1952, Dr. Bodian and his colleagues at Johns
Hopkins also demonstrated poliovirus in human blood.
During the early 1950's the Unit pursued its work in serological epidemi-
ology and under Dr. Melnick, many studies were carried out, developing
and modifying the new tissue culture techniques. Mr. John Riordan, Dr.
Edward Opton, and later Dr. Edith Hsiung and Dr. Francis Black par-
ticipated extensively in this work. In 1955 the laboratory began to plan and
carry out a series of field trials with the various oral poliovirus vaccines.
This latter work has more or less dominated the Yale Poliomyelitis Study
Unit program during the last several years. A series of live poliovirus vaccine
trials using Sabin's strains was carried out at the Southbury Training
School, by Drs. Paul, Horstmann, Niederman, and Deutsch in cooperation
with Dr. Herman Yannet, the medical director, of the institution. Another
trial was carried out among the Yaqui Indians in Southern Arizona, and
still another, using the Lederle vaccine, in a selected village population in
Costa Rica. All of these trials were set up in such a way as to yield in-
formation about the epidemiology and pathogenesis of poliomyelitis, as
well as about the safety and efficacy of live poliovirus vaccines. The
concept of local tissue immunity (in addition to humoral immunity) as
a major defense mechanism was advanced as a result of the observations
made. The responsibility of gathering information on the safety and
efficacy of the vaccine has been a concern of the Unit particularly because
the Director (Dr. Paul) has been a member of the Committee on Live
Poliovirus Vaccine of the National Institutes of Health in which im-
portant decisions concerning the use of oral vaccine have been considered
over the past three years.
It should be mentioned that during the past seven years the Yale
Poliomyelitis Study Unit has acted as the World Health Organization's
Laboratory of Poliomyelitis for the Americas. This is a Regional Labora-
tory which deals with certain problems of a reasearch and service nature
concerning this disease in the Latin American countries.
This report would not be complete without mentioning the names of those
fellows and younger members of the Section who have made a career for
themselves in the poliomyelitis field. The following in particular might
be mentioned at this time: Dr. Herbert A. Wenner, Research Professor of
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Pediatrics at the University of Kansas; Dr. Robert Ward, Professor of
Pediatrics at the University of Southern California Medical School; Dr.
Herdis von Magnus, Chief of the Piliomyelitis Department of the Statens
Seruminstitut of Copenhagen, Denmark; Dr. Sven Gard, Professor of
Virology, Karolinska Institute Stockholm, Sweden; Dr. Edward C.
Curnen, Professor of Pediatrics at the College of Physicians and Surgeons,
Columbia University, New York; and Dr. G. Contreras of Santiago, Chile,
Dr. Natan Goldblum of Israel, Dr. Ramos Alvarez of Mexico City, and
last but far from least, Dr. Joseph L. Melnick, Professor of Virology and
Epidemiology at Baylor University in Houston, Texas.
Since the establishment of the unit a series of more than 325 papers
on poliomyelitis have been published and a review of these titles has fairly
well covered the story of the disease during this thirty year period.
STUDIES ON VIRAL HEPATITIS
Yale's contribution to the study of the etiology of infectious hepatitis de-
serves some mention. One of the first tasks of the various commissions of the
Army Epidemiological Board, of which Francis G. Blake was appointed
president early in 1941, was to investigate the outbreak of hepatitis which
occurred in the Army as a result of the use of yellow fever vaccine among
troops in 1942. Until 1944-45 there was no appreciation of the fact that
there are two forms of hepatitis, the so-called infectious hepatitis and
serum hepatitis. Whether the difference between these two forms is due
to their being caused by two completely distinct viruses or by two varieties
of the same virus is still a moot point; but it is sufficient to state that there
are differences between the agents, and their modes of transmission differ,
however indistinguishable clinically the two diseases may be at times.
In 1942 most physicians in the United States, and for that matter in
the greater part of the world, recognized an epidemic form of mild jaundice,
distinct from Weil's disease. It was an ill-defined entity, however, rather
uncommon, and felt to be probably different from the common sporadic
disease known as catarrhal jaundice. The spirochetal jaundice of Weil's
disease was recognized as a diffuse hepatitis, whereas catarrhal jaundice
was considered to be an obstructive jaundice due to primary inflammation
of the bile ducts, and quite different in its pathology, prognosis, and clinical
picture. This view had been held for a long time despite the fact that
there was good clinical and epidemiologic evidence in the literature to
indicate that it was incorrect.
Dr. George Blumer of this School had been among the first in this
country to uphold the idea that catarrhal jaundice was the sporadic form of
178
Vol. 34., Dec.-Feb. 196112From the notebook of J. R. Paul
infectious hepatitis. His views were published in the Journal of the
American Medical Association in 1923, shortly after an epidemic had been
described among Yale students by Dr. Ira Hiscock among others. How-
ever, Dr. Blumer's view had been anticipated in a report by Cockayne in
England published in 1912, giving an historical review with the compre-
hensive title, "Catarrhal Jaundice, Sporadic and Epidemic, and Its Rela-
tion to Acute Yellow Atrophy of the Liver." Cockayne's views and also
those of Blumer received very little attention for many years. Catarrhal
jaundice, it was insisted, was a catarrh of the biliary tract in which mucus
plugs played a role. So strong was this view that one school championed
the idea that a rational, direct, and effective method of therapy was the
removal ofthis plugof inspissated mucus "corking" up the ampulla of Vater,
by the introduction of magnesium sulfate into the duodenum. The great
pathologist Virchow had described this plug and accounts of its supposed
importance had been carried through successive editions of many textbooks
(including the influential Osler's text) for almost two generations. Eppenger
in Vienna was the first to suggest that the pathogenesis of catarrhal
jaundice was really associated with hepatocellular necrosis. His paper was
published in 1922. Eight years later Eppenger's views were upheld by Dr.
Aronld Rich who, after studying the records of 11,500 autopsies performed
at the Johns Hopkins Hospital during 40 years, reported that there was not
a single case among them in which the diagnosis of "catarrhal jaundice"
could be regarded as accurate. Thus, it seems that the concept of the
pathogenesis of the clinical entity known as catarrhal jaundice had gone
beyond the facts.
Outbreaks of serum hepatitis on the other hand, dated back to about
1883, and were observed following vaccination for smallpox, the use of
arsphenamine in the treatment of syphilis, of insulin in diabetic clinics
and in other situations in which the parenteral administration of drugs was
used. Outstanding in the history of serum hepatitis were the cases which
occurred during World War II following vaccination against yellow fever.
At this time the virus used in yellow fever vaccine was grown in tissue
cultures containing human serum in the media. In spite of this information,
however, the epidemic of serum hepatitis fell upon the unsuspecting
American Army like the bombshells falling on Pearl Harbor. As a result,
many investigators in this country took upon themselves the study of a
comparison between epidemic hepatitis and serum hepatitis. There seemed
to be a difference: - one had a long incubation period ranging from 60
to 150 days, the other a shorter one from 15 to 40 days.
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A great advance in the study of infectious hepatitis took place when the
disease was first produced experimentally in man. In 1942, Voegt, in
Germany, reported the transmission of hepatitis to volunteers by feeding
them duodenal fluid or blood obtained from patients in the acute phase
of the disease. Unfortunately, published accounts of his experiments are
quite inadequate. In 1944, MacCallum and Bradley in England, at the
Jaundice Center of the British Medical Research Council, obtained some
highly significant experimental results. Their report, in the form of a
letter published in the Lancet on 12 August 1944, described success in trans-
mitting viral hepatitis to arthritic patients. Various routes of transmission
had been used and the infective material included feces given by mouth.
Independently, members of the Neurotropic Virus Commission here at
Yale working largely under the direction of Major W. Paul Havens were
successful in producing the disease in volunteers of Civilian Public Service
Units, composed of conscientious objectors who were quartered in New
Haven. These men were fed fecal specimens obtained from soldiers in
the Mediterranean area during the epidemic of 1943. The experiments
were begun in June and July of 1944, and the patients were housed on
the infectious disease wards of the New Haven Hospital. The first definite
experimental cases occurred in July and a report of this work was pre-
sented at the first meeting of the Hepatitis Study Group, held at the
Rockefeller Institute for Medical Research in New York on 12 July
1944. It was published in November 1944. It can be fairly stated that this
represented the first published successful demonstration in the United
States of the enteric-oral transmission of infectious hepatitis.
Other aspects of the disease which were investigated in New Haven
included the determination of the times at which virus could be found in
the blood and in feces, both before and after the onset of jaundice; and an
excellent study of the blood picture. Cross protection studies in volunteers
indicated a lack of cross immunity between serum and infectious hepatitis.
From this work, and from studies carried out elsewhere, a differentiation
between the two hepatitis viruses was established, and the present concept
of the two diseases emerged."
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